Gain Therapeutics Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Gain Therapeutics Inc had 16.54M in cash and cash equivalents.

Gain Therapeutics Inc reported 4.25M in total liabilities as of the latest reported quarter, including 3.35M in current liabilities and 901.83K in non-current liabilities.

As of the latest reported quarter, Gain Therapeutics Inc's total assets were 22.82M, consisting of 22.24M in current assets and 581.84K in non-current assets.

Gain Therapeutics Inc reported 18.56M in total shareholders' equity as of the latest reported quarter.